| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/05/2009 | CN101497851A Healthcare wine |
| 08/05/2009 | CN101497654A Melanocortin receptor agonists |
| 08/05/2009 | CN101497614A 1,2,3,5,11,11a- hexahydro-3,3-dimethyl-1-oxo-6H-glyoxaline [3', 4': 1,2] pyridine [3,4-b] diindyl-2-substituted methyl acetate, as well as preparation and application thereof |
| 08/05/2009 | CN101496892A Oral Chinese patent medicine for treating cardiovascular disease |
| 08/05/2009 | CN101496857A Blood-activating, stasis-resolving, qi-regulating and analgesic dropping pill and preparation method thereof |
| 08/05/2009 | CN101496853A Qi-benefitting, yin-nourishing, blood circulation-promoting and apophlegmatic dropping pill and preparation method thereof |
| 08/05/2009 | CN101496842A Chinese medicinal composition for regulating blood and moistening skin |
| 08/05/2009 | CN101496831A Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases |
| 08/05/2009 | CN101496826A Medicament for stretching channel, activating collaterals, compensating deficiency and invigorating yang |
| 08/05/2009 | CN101496819A Eubacterium, Clostridium preparation and use thereof |
| 08/05/2009 | CN101496813A Anti-hyperblastosis (vascular restenosis) composition and application method |
| 08/05/2009 | CN101496803A Application of compound taurine and ansiolin in preparing medicament for treating brain injury disease |
| 08/05/2009 | CN101496798A Use of salvianolic acid B |
| 08/05/2009 | CN101496797A Salvianolic acid A phospholipid complexes and preparation method thereof |
| 08/05/2009 | CN101496792A Punailuoer or delayed-release preparation of salt thereof and preparation method thereof |
| 08/05/2009 | CN101496787A Prostaglandin E1 lipid microsphere injection with charge effect and preparation method thereof |
| 08/05/2009 | CN100523212C Process for producing tripeptides |
| 08/05/2009 | CN100523198C Method for detection of leptin receptor ligands |
| 08/05/2009 | CN100523187C Modified chimeric polyeptides with improved pharmacokinetic properties |
| 08/05/2009 | CN100522997C Method and composition for treating cardiovascular diseases by employing neuroregulation protein |
| 08/05/2009 | CN100522976C Novel azacyclic ethynyl derivatives |
| 08/05/2009 | CN100522967C Phosphorus-containing compounds & uses thereof |
| 08/05/2009 | CN100522963C Pyrroloimidazole derivatives, their preparation, pharmaceutical composition containing them, and their use as nootropic agents |
| 08/05/2009 | CN100522946C Stabilization of hypoxia inducible factor (HIF) alpha |
| 08/05/2009 | CN100522945C Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and use thereof |
| 08/05/2009 | CN100522944C Carboxylic acid derivative and thereof |
| 08/05/2009 | CN100522943C Vitamin d analogues |
| 08/05/2009 | CN100522940C Derivatives of alpha-phenylthiocarboxylic and g(a)-phenyloxy-carboxylic acids useful for the treatment of diseases responding to PPAR alpha activation |
| 08/05/2009 | CN100522937C Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof |
| 08/05/2009 | CN100522204C A Chinese medicine for treating hypertension and hyperlipemia and method for preparing same |
| 08/05/2009 | CN100522196C Medicine or foods for prevention and treatment of microcirculation disorder and disease of live habits |
| 08/05/2009 | CN100522195C Medicine composition for treating cardiovascular and cerebrovascular diseases, preparation method and use thereof |
| 08/05/2009 | CN100522192C Method for preparing Chinese medicine particles for treating cardio-cerebral vascular diseases and its product |
| 08/05/2009 | CN100522191C Fingerprint atlas detection method for tanshin polyphenolic acid salts |
| 08/05/2009 | CN100522188C New use and preparation of smoke tree extract for Chinese medicine |
| 08/05/2009 | CN100522186C Sustained release capsules of ginkgo leaf and preparation method |
| 08/05/2009 | CN100522172C Non-sedating barbiturate compounds as neuroprotective agents |
| 08/05/2009 | CN100522169C Ranolazine hydrochloride slow-release preparation and its preparing method |
| 08/05/2009 | CN100522166C (1-4-piperidinyl) benzimidazole derivatives useful as histamine H3 antagonists |
| 08/05/2009 | CN100522164C Method of treating of demyelinating diseases or conditions |
| 08/05/2009 | CN100522159C The use of substituted azetidinone compounds for the treatment of sitosterolemia |
| 08/05/2009 | CN100522157C Treatment of diseases involving defective gap junctional communication |
| 08/05/2009 | CN100522156C Tanshinone IIA sodium sulfonate transfusion liquid, its preparation method and photophobic outer package |
| 08/05/2009 | CN100522150C Angiogenesis inhibitor |
| 08/05/2009 | CN100522146C Preparation method of Chinese traditional medicine slow release preparation for treating coronary heart disease and angina pectoris |
| 08/05/2009 | CN100522139C 'Mailuoning' injection and preparation method |
| 08/04/2009 | US7569585 Drugs; analgesics; anesthetics; antiarrhythmia agents; antiinflammatory agents ; incontinence; gastrointestinal disorders; neurodegenerative disease |
| 08/04/2009 | US7569572 Such as 2-dimethylamino-N-[5-dimethylamino-1-(2-ethoxyethyl)-7-(4-methylpyridin-2-ylamino)-1H-pyrazolo[4,3-d]pyrimidin-3-ylmethyl]acetamide; cyclic-gmp phosphodiesterase/3*,5*-/ inhibitors |
| 08/04/2009 | US7569567 3-Heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-B]indole-1-carboxamide derivatives, their preparation and therapeutic use |
| 08/04/2009 | CA2496476C Therapeutic use |
| 08/04/2009 | CA2434228C Biphenyl derivatives |
| 08/04/2009 | CA2433785C Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
| 08/04/2009 | CA2365281C Human antibodies that bind human il-12 and methods for producing |
| 08/04/2009 | CA2356212C Crystalline bis[(e)-7- [ 4-(4- fluorophenyl)- 6-isopropyl-2- [methyl (methylsulfonyl) amino] pyrimidin -5-yl] (3r,5s)-3, 5-dihydroxyhept -6-enoic acid]calcium salt |
| 08/04/2009 | CA2334727C Tetrahydroquinoline derivatives as glycine antagonists |
| 08/04/2009 | CA2207850C Use of mono and bicarboxylic acid amides for the manufacture of a medicament active at the peripheral cannabinoid receptor |
| 07/30/2009 | WO2009093972A1 Enantiomerically pure (-) 2-[1-(7-methyl-2-(morpholin-4-yl)-4-oxo-4h-pyrido[1,2-a]pyrimidin-9-yl)ethylamino]benzoic acid, its use in medical therapy, and a pharmaceutical composition comprising it - 026 |
| 07/30/2009 | WO2009093928A1 Agent for leg care against in case of chronic venous insufficiency of lower extremities |
| 07/30/2009 | WO2009093880A2 Treatment and prevention of cardiac conditions using two or more isoforms of hepatocyte growth factor |
| 07/30/2009 | WO2009093755A1 Agent for increasing blood adiponectin quantity |
| 07/30/2009 | WO2009093650A1 Prostaglandin-containing fat emulsion and method for producing the same |
| 07/30/2009 | WO2009093471A1 Apoptosis inhibitor |
| 07/30/2009 | WO2009093384A1 Polynucleotide or analogue thereof, and gene expression regulation method using the polynucleotide or the analogue thereof |
| 07/30/2009 | WO2009093264A2 Pharmaceutical combinations comprising specified age breaker and further drugs, i.a. antihypertensive drugs, antidiabetic drugs etc. |
| 07/30/2009 | WO2009093049A1 Fused pyridines active as inhibitors of c-met |
| 07/30/2009 | WO2009092442A1 Treatment of portal hypertension and related conditions by combined inhibition of the vegf and pdgf signalling pathways |
| 07/30/2009 | WO2009092358A1 Induction and promotion of arteriogenesis |
| 07/30/2009 | WO2009092301A1 Dihydropyridine calcium antagonist compounds, preparation methods and medical uses thereof |
| 07/30/2009 | WO2009092284A1 Benzocycloheptene derivatives, preparing processes and pharmaceutical uses thereof |
| 07/30/2009 | WO2009092133A1 Methods for identifying compounds capable of treating or preventing a diabetic complication via set7 or suv39 methyltransferases |
| 07/30/2009 | WO2009074674A3 Trisubstituted piperidines as renin inhibitors |
| 07/30/2009 | WO2009050228A3 Csf-1r inhibitors for treatment of cancer and bone diseases |
| 07/30/2009 | WO2009043464A3 Astressin and beta- endorphin for use as therapeutic agents |
| 07/30/2009 | WO2009043451A3 Use of chorionic gonadotropin-beta (109-145) as a therapeutic agent |
| 07/30/2009 | WO2009043450A3 Use of neurotrophic factor for retinal cholinergic neurons (nfrcn) and chorionic gonadotropin-beta (109-145) as therapeutic agents |
| 07/30/2009 | WO2009043449A3 Use of a peptide as a therapeutic agent |
| 07/30/2009 | WO2009043447A3 Use of a peptide as a therapeutic agent |
| 07/30/2009 | WO2009040085A3 Use of exendin-4 and optionally salusin-alpha as therapeutic agent(s) |
| 07/30/2009 | WO2009040004A3 Use of a peptide as a therapeutic agent |
| 07/30/2009 | WO2009034541A3 Controlled release pharmaceutical dosage forms of trimetazidine |
| 07/30/2009 | WO2009033813A3 Use of a peptide as a therapeutic agent |
| 07/30/2009 | WO2009033774A3 Use of a laminin nonapeptide as a therapeutic agent |
| 07/30/2009 | WO2009033769A3 Use of cortistatin 14 and others as a therapeutic agent |
| 07/30/2009 | WO2009033722A8 Use of a octreotide as a therapeutic agent |
| 07/30/2009 | WO2008134445A8 Platelet activation receptor clec-2: compositions and uses thereof |
| 07/30/2009 | WO2008101700A3 Bispecific fusion protein having therapeutic and diagnostic potential |
| 07/30/2009 | WO2008054825A8 Mixed cell populations for tissue repair and separation technique for cell processing |
| 07/30/2009 | WO2008052044A3 Use of derivatives of propofol for treating diseases associated with oxidative stress |
| 07/30/2009 | WO2007112753A8 Pharmaceutical composition comprising anti-mirna antisense oligonucleotides |
| 07/30/2009 | WO2007088460A8 Tgf-beta modulators and use thereof |
| 07/30/2009 | US20090192179 Chroman derivatives |
| 07/30/2009 | US20090192177 2-ARYL pyrrologpyrimidines for A1 and A3 receptors |
| 07/30/2009 | US20090192171 5-Lipoxygenase-Activating Protein (FLAP) Inhibitors |
| 07/30/2009 | US20090192168 Compounds, Compositions and Methods |
| 07/30/2009 | US20090192156 Phthalazinone derivatives |
| 07/30/2009 | US20090192150 protease-activated receptor 1 (PAR1) inhibitors such as 1-(3,5-di-tert-butyl-4-hydroxyphenyl)-2-(3-iminoimidazo[1,5-a]pyridin-2-yl)ethanone, used as anticoagulants |
| 07/30/2009 | US20090192144 Imidazo Compounds |
| 07/30/2009 | US20090192138 compounds |
| 07/30/2009 | US20090192129 Bicyclic pyrrole derivatives |
| 07/30/2009 | US20090192089 treatment of cell damage caused by ischemia or stroke by administering to a cell or a tissue an effective amount of an isozyme specific delta PKC (protein kinase C) antagonist |